Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells
- PMID: 3860831
- PMCID: PMC390464
- DOI: 10.1073/pnas.82.15.4896
Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells
Abstract
The recent observation made in our laboratory that cellular myc (c-myc) mRNA has a very short half-life in a variety of normal and transformed human cells emphasized the potential importance of post-transcriptional regulation of c-myc gene expression. Jonak and Knight [Jonak, G. J. & Knight, E., Jr. (1984) Proc. Natl. Acad. Sci. USA 81, 1747-1750] have reported a selective reduction of c-myc mRNA accumulation in lymphoblastoid Daudi cells treated with human beta interferon. This provided a suitable situation in which to examine a possible action of negative modulators of c-myc expression at the level of mRNA stability. Our results confirm the observation by Jonak and Knight that c-myc mRNA level is depressed in cells treated with beta interferon and extend it to alpha 2 interferon. Furthermore, we now demonstrate that interferon has no effect on c-myc transcription rate in isolated nuclei but rather reduces the half-life of its mRNA. Conversely, we show that it increases the level of HLA-A2 mRNA by stimulating its transcription.
Similar articles
-
Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level.Proc Natl Acad Sci U S A. 1985 Feb;82(4):1151-4. doi: 10.1073/pnas.82.4.1151. Proc Natl Acad Sci U S A. 1985. PMID: 3856253 Free PMC article.
-
Selective reduction of c-myc mRNA in Daudi cells by human beta interferon.Proc Natl Acad Sci U S A. 1984 Mar;81(6):1747-50. doi: 10.1073/pnas.81.6.1747. Proc Natl Acad Sci U S A. 1984. PMID: 6584908 Free PMC article.
-
Extreme instability of myc mRNA in normal and transformed human cells.Proc Natl Acad Sci U S A. 1984 Nov;81(22):7046-50. doi: 10.1073/pnas.81.22.7046. Proc Natl Acad Sci U S A. 1984. PMID: 6594679 Free PMC article.
-
Interferon modulation of c-myc expression in cloned Daudi cells: relationship to the phenotype of interferon resistance.Mol Cell Biol. 1986 May;6(5):1374-8. doi: 10.1128/mcb.6.5.1374-1378.1986. Mol Cell Biol. 1986. PMID: 3785169 Free PMC article.
-
The evolving role of alpha interferon in the treatment of malignancies.Aust N Z J Med. 1986 Jun;16(3):425-37. doi: 10.1111/j.1445-5994.1986.tb01212.x. Aust N Z J Med. 1986. PMID: 3535771 Review. No abstract available.
Cited by
-
Mechanism of interferon action: alpha and gamma interferons differentially affect mRNA levels of the catalytic subunit of protein kinase A and protein Mx in human cells.J Virol. 1992 Apr;66(4):2519-22. doi: 10.1128/JVI.66.4.2519-2522.1992. J Virol. 1992. PMID: 1548777 Free PMC article.
-
Posttranscriptional regulation of c-myc proto-oncogene expression and growth inhibition by recombinant human interferon-beta ser17 in a human colon carcinoma cell line.Cancer Chemother Pharmacol. 1992;30(1):12-20. doi: 10.1007/BF00686479. Cancer Chemother Pharmacol. 1992. PMID: 1586975
-
Transcriptional and posttranscriptional control of c-myc gene expression in WEHI 231 cells.Mol Cell Biol. 1986 Nov;6(11):4112-6. doi: 10.1128/mcb.6.11.4112-4116.1986. Mol Cell Biol. 1986. PMID: 3796600 Free PMC article.
-
1,25-Dihydroxyvitamin D3 modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating factor) posttranscriptionally.J Clin Invest. 1988 Jun;81(6):1819-23. doi: 10.1172/JCI113525. J Clin Invest. 1988. PMID: 3290254 Free PMC article.
-
A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability.J Virol. 1991 Apr;65(4):2093-7. doi: 10.1128/JVI.65.4.2093-2097.1991. J Virol. 1991. PMID: 1848319 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials